Clinton Collins, MD
Urology · Jackson, MSNPI 1932318243
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,137 of the $4,012 with a category attached, or 78.2%. It is spread thinly across 29 manufacturers, the largest accounting for just 22.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $1,126 and has fallen 65.2% since, to $391 in 2025. That places this record below the midpoint for urology clinicians in MS, where the typical reported total is $3,535.
Across 134 payments — averaging $29.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neotract Inc.$906
- Coloplast$579
- Teleflex LLC$368
- Astellas Pharma US Inc$333
- Boston Scientific$324
- Axonics, Inc.$213
- plus $1K from 23 others
What the payments were for
- Travel & lodging$57714%
- Food & beverage$3,13778%
- Education$2977%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neotract Inc. | 12 | $906 |
| Coloplast | 27 | $579 |
| Teleflex LLC | 8 | $368 |
| Astellas Pharma US Inc | 15 | $333 |
| Boston Scientific | 8 | $324 |
| Axonics, Inc. | 5 | $213 |
| AbbVie(2 entities) | 12 | $209 |
| Endo Pharmaceuticals Inc. | 10 | $145 |
| Calyxo, Inc. | 1 | $141 |
| Urogen Pharma, Inc. | 3 | $90 |
| Caldera Medical, Inc | 1 | $74 |
| Tolmar Pharmaceuticals, Inc. | 4 | $71 |
| C. R. Bard, Inc. & Subsidiaries | 3 | $62 |
| Sumitomo Pharma America, Inc. | 3 | $61 |
| Procept Biorobotics Corporation | 2 | $60 |
| Urovant Sciences Inc | 3 | $48 |
| Escala Medical Inc. | 1 | $48 |
| Rochester Medical Corporation | 2 | $47 |
| Ferring Pharmaceuticals Inc. | 2 | $38 |
| Pfizer | 2 | $31 |
| Bayer | 2 | $26 |
| Hollister Incorporated | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| Angiodynamics, Inc. | 1 | $20 |
| Zyla Life Sciences, Inc. | 1 | $18 |
| Dentsply IH Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Myovant Sciences Inc. | 1 | $13 |
| Laborie Medical Technologies Corp. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UroLift$820
- Barrigel$150
- FEMALE INCONTINENCE$142
- CVAC Aspiration System$141
- Axonics$115
How this compares
$4,012 in reported general payments places this provider in the 50th percentile of 94 urology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 325 | $267,374 |
| MyrbetriqMirabegron | 151 | $95,916 |
| PremarinEstrogens, Conjugated | 34 | $15,032 |
| Methenamine Hippurate | 100 | $5,440 |
| Tamsulosin Hcl | 353 | $4,790 |
| Trospium Chloride | 66 | $4,512 |
| Finasteride | 315 | $3,104 |
| NitrofurantoinNitrofurantoin Macrocrystal | 71 | $1,708 |
| Silodosin | 21 | $1,589 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 41 | $1,562 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 45 | $736 |
| Cefdinir | 52 | $629 |
| Ciprofloxacin Hcl | 88 | $605 |
| Tolterodine Tartrate ErTolterodine Tartrate | 27 | $546 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 32 | $514 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $61 | $267,374325 claims |
| Astellas Pharma US IncMyrbetriq | $333 | $95,916151 claims |
| PfizerPremarin | $31 | $15,03234 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 94 urology providers in Mississippi.
Other urology in Jackson
- Harold BlalockJackson$15K
- Patrick DailyJackson$12K
- Mark RunnelsJackson$10K
- Allen HarawayJackson$8K
- John AdamsJackson$8K
- Michael WoodJackson$8K
- Chadwick HuckabayJackson$8K
- Ronald DavisJackson$6K
- Felix Gordon JrJackson$6K
- Kieran HynesJackson$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.